Brooks, J. P., Rice, A. J., Ji, W., Lanahan, S. M., Konstantino, M., Dara, J., … Lucas, C. L. (2021). Uncontrolled Epstein-Barr Virus as an Atypical Presentation of Deficiency in ADA2 (DADA2). J Clin Immunol, 41(3), 680–683. https://doi.org/10.1007/s10875-020-00940-1

Brooks, Joel P., Andrew J. Rice, Weizhen Ji, Stephen M. Lanahan, Monica Konstantino, Jasmeen Dara, Michael S. Hershfield, et al. “Uncontrolled Epstein-Barr Virus as an Atypical Presentation of Deficiency in ADA2 (DADA2).” J Clin Immunol 41, no. 3 (April 2021): 680–83. https://doi.org/10.1007/s10875-020-00940-1.

Brooks JP, Rice AJ, Ji W, Lanahan SM, Konstantino M, Dara J, et al. Uncontrolled Epstein-Barr Virus as an Atypical Presentation of Deficiency in ADA2 (DADA2). J Clin Immunol. 2021 Apr;41(3):680–3.

Brooks, Joel P., et al. “Uncontrolled Epstein-Barr Virus as an Atypical Presentation of Deficiency in ADA2 (DADA2).” J Clin Immunol, vol. 41, no. 3, Apr. 2021, pp. 680–83. Pubmed, doi:10.1007/s10875-020-00940-1.

Brooks JP, Rice AJ, Ji W, Lanahan SM, Konstantino M, Dara J, Hershfield MS, Cruickshank A, Dokmeci E, Lakhani S, Lucas CL. Uncontrolled Epstein-Barr Virus as an Atypical Presentation of Deficiency in ADA2 (DADA2). J Clin Immunol. 2021 Apr;41(3):680–683.